Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06107972
Other study ID # HSC-MS-23-0188
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 29, 2023
Est. completion date January 31, 2025

Study information

Verified date February 2024
Source The University of Texas Health Science Center, Houston
Contact Antonio Pagan, PhD
Phone (713) 486-2700
Email Antonio.Pagan@uth.tmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the acceptability, feasibility (e.g., satisfaction, completion rate, barriers to recruitment, treatment fidelity) of the culturally refined Launching! to Adulthood (¡Iniciando! la Adultez) program, to test for a preliminary signal of effect between baseline and post-treatment for the Launching! to Adulthood (¡Iniciando! la Adultez) program and to identify preliminary neural mechanisms of action, including biomarkers of brain structure and connectivity, in terms of treatment response for 15 Latino young adults participating in the ¡Iniciando! therapy program.


Description:

The Launching! to Adulthood (¡Iniciando! la Adultez) program uses a culturally sensitive therapy program that was translated into Spanish to help Latino young adults with Autism Spectrum Disorder (ASD) who are transitioning to adulthood (18-25 years old) and their parents. The program aims to make the transition to adulthood easier for young adults and their families, and it includes specific cultural values of Latino young adults and their family members. The ¡Iniciando! la adultez program helps autistic young adults manage mental health needs like depression and anxiety and also addresses several areas impacting transition, including mental health barriers, executive functioning, and motivation. The ¡Iniciando! program also helps parents manage their own needs and addresses several areas, including psychoeducation and mental health.


Recruitment information / eligibility

Status Recruiting
Enrollment 58
Est. completion date January 31, 2025
Est. primary completion date April 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - confirmed case of ASD - a score of >14 on the Social Communication Questionnaire-Lifetime (SCQ-L110) completed with the mother or father - meet DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 ASD symptom checklist - previous diagnosis of ASD from a licensed mental health or medical professional - speak English - have a parent willing to participate (treatment group only) - score >85 on verbal intelligence quotient (IQ) on the Kaufman Brief Intelligence Test (KBIT-2) Exclusion Criteria: - history of a psychotic disorder or current psychotic symptoms - suicidal ideation with intent or plan - current alcohol or other substance use disorder rated severe - concurrent enrollment in another clinical trial for autism spectrum disorder - expression of unwillingness to complete study procedures - For fMRI, unable to undergo fMRI scanning due to metallic devices or objects (cardiac pacemaker or neurostimulator, some artificial joints, metal pins, surgical clips, or other implanted metal parts) or claustrophobic to the scanner.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Launching! to Adulthood (¡Iniciando! la Adultez) program
The program includes cognitive behavioral and acceptance and commitment therapy, with a focus on developing goals during the transition to adulthood through a values framework. After a combined (parents and young adults) 90-minute introductory group meeting in-person, parents and the transition-aged young adults with ASD attend 9 separate, 90-minute weekly group telehealth meetings. Additionally, young adults have weekly personal coaching meetings for 30-minutes to discuss progress toward goals and barriers encountered. Leaders teach transition-aged young adult's skills through various social activities, as well as other skills (e.g., emotion regulation, cognitive diffusion) to help overcome barriers towards their goals. The treatment targets three core factors (i.e., mental health conditions, social skills, and coping with and adapting to stress). Leaders teach parents new parenting skills, knowledge of ASD, and readiness to support their young adult's transition to independent life.

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston UTHealth Houston Seed Grant and Autism Speaks Fellowship

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in adaptive behavior as assessed by the Adaptive Behaviour Assessment System, Third Edition This is a 239 item questionnaire and each is scored from 0(is not able to do this behavior) to 3 [(always able to do this behavior)(or almost always)] a higher number indicating better outcome baseline, mid-treatment (5 weeks after baseline) , post-treatment (10 weeks after baseline), 3 month follow up, 6 month follow up
Primary Change in Quality of life as assessed by the Autism Spectrum Quality of Life (ASQoL) questionnaire This is a 9 item questionnaire. Questions 1-5 and 9 are each scored from 1(not at all) to 5(totally) a higher number indicating better outcome and questions 6-8 are reverse scored from 5(never) to 1(always) a higher score indicating worse outcome baseline, mid-treatment (5 weeks after baseline) , post-treatment (10 weeks after baseline), 3 month follow up, 6 month follow up
Primary Change in Anxiety as assessed by the Generalized Anxiety Disorder-7 (GAD7) This is a 7 item questionnaire and each is scored from 0(not at all) to 4(nearly every day) for a maximum score of 21 , higher score indicating more anxiety baseline, mid-treatment(5 weeks after baseline) , post-treatment (10 weeks after baseline), 3 month follow up, 6 month follow up
Primary Change in depression as assessed by the Patient Health Questionnaire (PHQ-9) This is a 9 item questionnaire and each is scored from 0(not at all) to 3(nearly every day) for a maximum score of 27, higher number indicating worse outcome baseline, mid-treatment(5 weeks after baseline) , post-treatment (10 weeks after baseline), 3 month follow up, 6 month follow up
Secondary Change in caregiver burden as assessed by the Rapid Screen for Caregiver Burden (CBI) This is a 24 item questionnaire, each item is given a score between 0 (not at all descriptive) and 4 (very descriptive), where higher scores indicate greater caregiver burden baseline, mid treatment (5 weeks after baseline) , post-treatment (10 weeks after baseline), 3 month follow up, 6 month follow up
Secondary Change in efficacy of coping with life's challenges as assessed by the Coping Self-Efficacy Scale (CSES) This is a 26 item questionnaire and each is scored on a 11-point scale from 0(cannot do at all)-10 (certain can do) and higher number indicates better outcome baseline, mid treatment (5 weeks after baseline) , post-treatment (10 weeks after baseline),3 month follow up, 6 month follow up
Secondary Change in stress as assessed by the Riverside Acculturation Stress Inventory (RASI) This is a 15-item scale and each is scored on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree) higher number indicates worse outcome baseline, mid treatment (5 weeks after baseline) , post-treatment (10 weeks after baseline), 3 month follow up, 6 month follow up
Secondary Change in goal attainment Goal Attainment Scaling (GAS) This is scored on a 5-point scale, with the degree of attainment captured for each goal area: If the patient achieves the expected level, this is scored at 0. If they achieve a better than expected outcome this is scored at: +1 (somewhat better) +2 (much better) If they achieve a worse than expected outcome this is scored at: -1 (somewhat worse) or -2 (much worse) Goals may be weighted to take account of the relative importance of the goal to the individual, and/or the anticipated difficulty of achieving it. week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 9, week 10
See also
  Status Clinical Trial Phase
Completed NCT05207956 - App for Strengthening Services In Specialized Therapeutic Support N/A
Completed NCT03286621 - Development of Eye-tracking Based Markers for Autism in Young Children
Completed NCT02608333 - Efficiency of Early Intervention for Autism Spectrum Disorder N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Active, not recruiting NCT06259539 - A YouTube Curriculum for Children With Autism and Obesity N/A
Active, not recruiting NCT06303791 - Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders N/A
Enrolling by invitation NCT05017779 - A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth N/A
Completed NCT04772898 - Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder N/A
Recruiting NCT04987541 - The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder N/A
Completed NCT04308915 - Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders N/A
Completed NCT06038435 - The Effect of Cognitive Orientation Approach on Daily Occupational Performance With Autism Spectrum Disorder N/A
Terminated NCT04049981 - Investigation of Mechanisms of Action in Superpower Glass Phase 1/Phase 2
Completed NCT03693313 - The Effect of CrossFit Kids on Social Skills in Children With Autism Spectrum Disorder (CrossFit KAMP) N/A
Recruiting NCT04107064 - Achieving Steady Work Among Adults With Autism Through Specialized Employment Program N/A
Recruiting NCT03812068 - Parent-mediated Developmental Behavioral Intervention N/A
Completed NCT03206996 - Exposure Therapy for Auditory Sensitivity in Autism N/A
Completed NCT02299700 - Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder N/A
Completed NCT03422016 - Electroretinogram in Autistic Spectrum Disorders
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Recruiting NCT05114538 - Improving the Part C Early Intervention Service Delivery System for Children With ASD N/A